KoBioLabs, Inc (KOSDAQ:348150)

KoBioLabs Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,063	5,689	10,047	10,433	52,693	40,627
Short-Term Investments	44,643	50,141	56,194	82,514	33,989	10,348
Trading Asset Securities	-	-	-	-	2,003	-
Cash & Short-Term Investments	50,706	55,830	66,240	92,947	88,685	50,975
Cash Growth	-24.64%	-15.72%	-28.73%	4.81%	73.98%	54.84%
Accounts Receivable	1,660	2,413	1,858	701.91	199.2	2,678
Other Receivables	399.19	917.9	3,020	4,279	3,118	2,475
Receivables	2,059	3,331	4,878	4,991	3,437	5,153
Inventory	6,369	4,468	1,467	977.47	256.21	105.56
Prepaid Expenses	1,378	910.68	1,765	1,852	2,133	1,442
Other Current Assets	1,960	2,143	1,378	1,711	4,108	134.87
Total Current Assets	62,472	66,682	75,729	102,478	98,619	57,810
Property, Plant & Equipment	30,599	31,172	34,858	20,485	5,791	383.21
Long-Term Investments	2,560	2,560	2,484	0	0	-0
Other Intangible Assets	623.54	642.24	637.67	279.6	324.2	300.73
Other Long-Term Assets	1,048	1,039	914.62	687.14	541.7	43.32
Total Assets	97,303	102,096	114,623	123,930	105,285	58,537
Accounts Payable	13.82	3.55	-	-	-	-
Accrued Expenses	1,016	1,756	1,127	763.8	543.31	385.63
Short-Term Debt	2,784	3,791	8,633	1,700	-	-
Current Portion of Long-Term Debt	712.16	3,830	58.36	-	1,515	-
Current Portion of Leases	89.14	130.21	234.21	136.51	24.6	28.77
Current Unearned Revenue	583.91	633.16	775.09	120.24	632.53	270.89
Other Current Liabilities	4,100	3,678	10,323	6,223	4,124	2,404
Total Current Liabilities	9,299	13,822	21,151	8,944	6,840	3,089
Long-Term Debt	11,507	8,671	9,172	11,765	7,633	-
Long-Term Leases	96.73	118.06	195.96	180.53	24.37	57.1
Other Long-Term Liabilities	24,008	24,007	22,285	7,586	200	-
Total Liabilities	44,911	46,618	52,804	28,475	14,697	3,146
Common Stock	9,709	9,687	9,436	8,722	8,135	7,759
Additional Paid-In Capital	215,118	215,260	219,114	220,581	208,053	158,760
Retained Earnings	-170,726	-168,125	-162,827	-148,975	-127,053	-111,671
Comprehensive Income & Other	-18,905	-18,997	-21,022	-3,736	577.08	543
Total Common Equity	35,196	37,825	44,702	76,592	89,713	55,391
Minority Interest	17,102	17,558	16,868	18,132	-	-
Shareholders' Equity	52,392	55,477	61,819	95,455	90,589	55,391
Total Liabilities & Equity	97,303	102,096	114,623	123,930	105,285	58,537
Total Debt	15,189	16,540	18,294	13,782	9,197	85.87
Net Cash (Debt)	35,516	39,290	47,946	79,165	79,488	50,889
Net Cash Growth	-15.05%	-18.05%	-39.43%	-0.41%	56.20%	55.09%
Net Cash Per Share	1839.43	2048.20	2587.95	4713.30	4953.80	4747.27
Filing Date Shares Outstanding	19.42	19.37	18.87	17.44	16.27	15.52
Total Common Shares Outstanding	19.42	19.37	18.87	17.44	16.27	15.52
Working Capital	53,173	52,860	54,578	93,535	91,779	54,721
Book Value Per Share	1812.47	1952.37	2368.65	4390.83	5513.80	3569.33
Tangible Book Value	34,573	37,183	44,064	76,312	89,388	55,090
Tangible Book Value Per Share	1780.36	1919.22	2334.86	4374.80	5493.88	3549.95
Land	6,477	6,477	6,477	6,477	-	-
Buildings	14,322	14,308	16,563	5,925	-	-
Machinery	10,927	10,862	4,569	3,920	859.78	634.9
Construction In Progress	-	-	8,766	4,929	5,321	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.